Elizabeth V. Nguyen

Melbourne, VIC 3800, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Activation of CAMK2 by pseudokinase PEAK1 represents a targetable pathway in triple negative breast cancer.

Activation of CAMK2 by pseudokinase PEAK1 represents a targetable pathway in triple negative breast cancer.

Journal: Nature communications
Published: March 07, 2024

Feed-forward stimulation of CAMK2 by the oncogenic pseudokinase PEAK1 generates a therapeutically "actionable" signalling axis in triple negative breast cancer.

Feed-forward stimulation of CAMK2 by the oncogenic pseudokinase PEAK1 generates a therapeutically "actionable" signalling axis in triple negative breast cancer.

Journal: bioRxiv : the preprint server for biology
Published: February 26, 2024

Proteome-based molecular subtyping and therapeutic target prediction in gastric cancer.

Proteome-based molecular subtyping and therapeutic target prediction in gastric cancer.

Journal: Molecular oncology
Published: August 02, 2023

Cell-Type-Specific Signalling Networks Impacted by Prostate Epithelial-Stromal Intercellular Communication.

Cell-Type-Specific Signalling Networks Impacted by Prostate Epithelial-Stromal Intercellular Communication.

Journal: Cancers
Published: December 09, 2022

A Boolean-based machine learning framework identifies predictive biomarkers of HSP90-targeted therapy response in prostate cancer.

A Boolean-based machine learning framework identifies predictive biomarkers of HSP90-targeted therapy response in prostate cancer.

Journal: Frontiers in molecular biosciences
Published: November 10, 2022

Proteomic characterisation of prostate cancer intercellular communication reveals cell type-selective signalling and TMSB4X-dependent fibroblast reprogramming.

Proteomic characterisation of prostate cancer intercellular communication reveals cell type-selective signalling and TMSB4X-dependent fibroblast reprogramming.

Journal: Cellular oncology (Dordrecht, Netherlands)
Published: September 12, 2022

The pseudokinase NRBP1 activates Rac1/Cdc42 via P-Rex1 to drive oncogenic signalling in triple-negative breast cancer.

The pseudokinase NRBP1 activates Rac1/Cdc42 via P-Rex1 to drive oncogenic signalling in triple-negative breast cancer.

Journal: Oncogene
Published: April 14, 2022

Distinct PEAK3 interactors and outputs expand the signaling potential of the PEAK pseudokinase family.

Distinct PEAK3 interactors and outputs expand the signaling potential of the PEAK pseudokinase family.

Journal: Science signaling
Published: February 22, 2022

Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived models.

Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived models.

Journal: Breast cancer research : BCR
Published: February 02, 2021

INPP4B promotes PI3Kα-dependent late endosome formation and Wnt/β-catenin signaling in breast cancer.

INPP4B promotes PI3Kα-dependent late endosome formation and Wnt/β-catenin signaling in breast cancer.

Journal: Nature communications
Published: October 06, 2020

Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.

Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.

Journal: Molecular cancer research : MCR
Published: June 26, 2020

FGFR3 signaling and function in triple negative breast cancer.

FGFR3 signaling and function in triple negative breast cancer.

Journal: Cell communication and signaling : CCS
Published: October 10, 2019
Showing 1-12 of 17

Last Updated: 09/26/2026